ML&R Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$317K Buy
408
+55
+16% +$39.1K 0.07% 56
2023
Q4
$206K Buy
+353
New +$206K 0.05% 71

Other funds holding LLY

ML&R Wealth Management's LLY Position: Q1 2024 in Review

ML&R Wealth Management increased its Eli Lilly (LLY) stake by 16% in Q1 2024, buying an estimated $39.1K and bringing the position to 408 shares worth $317K. The position accounts for 0.07% of the portfolio, ranked #56.

ML&R Wealth Management first reported a position in LLY in Q4 2023 and has held it in 2 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • ML&R Wealth Management held 408 shares of Eli Lilly worth $317K as of Q1 2024.
  • ML&R Wealth Management bought 55 Eli Lilly shares in Q1 2024, an estimated $39.1K.
  • Eli Lilly made up 0.07% of ML&R Wealth Management's portfolio in Q1 2024, its #56 holding.
  • ML&R Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 2 quarters since.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on ML&R Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.